SkinHealth Systems Inc. SKIN
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -6.46% | -8.17% | -10.02% | -13.15% | -15.34% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -6.46% | -8.17% | -10.02% | -13.15% | -15.34% |
| Cost of Revenue | -12.37% | -21.26% | -27.48% | -42.88% | -54.32% |
| Gross Profit | -3.14% | 0.90% | 3.19% | 15.96% | 62.28% |
| SG&A Expenses | -16.83% | -18.17% | -13.22% | -11.31% | -9.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -14.79% | -18.71% | -18.39% | -24.51% | -31.70% |
| Operating Income | 87.83% | 80.69% | 65.20% | 74.52% | 74.64% |
| Income Before Tax | -27.94% | 90.52% | 79.91% | 51.76% | 77.00% |
| Income Tax Expenses | 925.27% | 127.93% | 892.26% | -171.67% | -85.05% |
| Earnings from Continuing Operations | -49.61% | 84.28% | 67.29% | 58.31% | 77.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -49.61% | 84.28% | 67.29% | 58.31% | 77.29% |
| EBIT | 87.83% | 80.69% | 65.20% | 74.52% | 74.64% |
| EBITDA | 360.30% | 159.04% | 117.42% | 115.36% | 92.58% |
| EPS Basic | -44.02% | 85.12% | 68.05% | 57.96% | 75.52% |
| Normalized Basic EPS | -124.23% | 90.82% | 89.46% | 91.97% | 90.55% |
| EPS Diluted | 19.60% | 57.14% | 52.42% | 47.10% | 65.92% |
| Normalized Diluted EPS | -89.37% | 86.63% | 84.73% | 87.87% | 88.42% |
| Average Basic Shares Outstanding | 2.42% | 2.20% | 2.06% | 0.57% | -1.74% |
| Average Diluted Shares Outstanding | 0.29% | 2.05% | -2.83% | -4.18% | -6.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |